Inventor · disambiguated record
Quinn Deveraux
Also filed as: DEVERAUX QUINN · DEVERAUX QUINN L
38 granted patents·19 pending applications·300 citations·filing 1998–2024
97Inventor score
Top patents by PatentIndex Score
57 records- 0197US9045541B2CD47 antibodies and methods of use thereofINHIBRX LLC·Filed 2013·Granted Jun 2, 2015·78 cites·21 claims
- 0296US10723785B2Serpin fusion polypeptides and methods of use thereofINHIBRX INC·Filed 2018·Granted Jul 28, 2020·9 cites·15 claims
- 0395US9663575B2CD47 antibodies and methods of use thereofINHIBRX LP·Filed 2015·Granted May 30, 2017·22 cites·22 claims
- 0493US10730929B2Serpin fusion polypeptides and methods of use thereofINHIBRX INC·Filed 2015·Granted Aug 4, 2020·5 cites·15 claims
- 0592US11866507B2Multispecific polypeptide constructs having constrained CD3 binding and methods of using the sameINHIBRX INC·Filed 2018·Granted Jan 9, 2024·8 cites·10 claims
- 0692US8980266B2Serpin fusion polypeptides and methods of use thereofECKELMAN BRENDAN·Filed 2012·Granted Mar 17, 2015·23 cites·22 claims
- 0791US10526397B2Non-immunogenic single domain antibodiesINHIBRX INC·Filed 2016·Granted Jan 7, 2020·10 cites·24 claims
- 0890US9920109B2Serpin fusion polypeptides and methods of purification thereofINHIBRX LLC·Filed 2013·Granted Mar 20, 2018·9 cites·14 claims
- 0988US11046752B2Serpin fusion polypeptides and methods of use thereofINHIBRX LP·Filed 2019·Granted Jun 29, 2021·3 cites·7 claims
- 1088US10501551B2Multivalent and multispecific 41BB-binding fusion proteinsINHIBRX INC·Filed 2017·Granted Dec 10, 2019·7 cites·64 claims
- 1188US10400029B2Serpin fusion polypeptides and methods of use thereofINHIBRX LP·Filed 2014·Granted Sep 3, 2019·6 cites·7 claims
- 1288US9914765B2WAP domain fusion polypeptides and methods of use thereofINHIBRX LLC·Filed 2015·Granted Mar 13, 2018·10 cites·7 claims
- 1388US9790280B2Monoclonal canine CD20 antibodies and methods of useELANCO TIERGESUNDHEIT AG·Filed 2012·Granted Oct 17, 2017·13 cites·7 claims
- 1488US7229617B2Methods and compositions for inducing apoptosis in cancer cellsIRM LLC·Filed 2003·Granted Jun 12, 2007·35 cites·16 claims
- 1587US2025011394A1Serpin fusion polypeptides and methods of use thereofSANOFI AATD INC·Filed 2024·Application pending·0 cites
- 1684US11117972B2Multivalent and multispecific OX40-binding fusion proteinsINHIBRX INC·Filed 2019·Granted Sep 14, 2021·2 cites·20 claims
- 1784US10093742B2Multispecific GITR-binding fusion proteins and methods of use thereofINHIBRX INC·Filed 2016·Granted Oct 9, 2018·4 cites·57 claims
- 1884US2025250349A1Uses of pdl1-binding proteinsINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1983US10308720B2Multivalent and multispecific DR5-binding fusion proteinsINHIBRX INC·Filed 2016·Granted Jun 4, 2019·3 cites·24 claims
- 2083US8986688B2WAP domain fusion polypeptides and methods of use thereofTIMMER JOHN·Filed 2012·Granted Mar 24, 2015·11 cites·24 claims
- 2183US2024376220A1Multivalent and Multispecific DR5-Binding Fusion ProteinsINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2281US12187804B2Multivalent and multispecific 41BB-binding proteinsINHIBRX BIOSCIENCES INC·Filed 2022·Granted Jan 7, 2025·0 cites·12 claims
- 2381US7172880B2Inhibitor of apoptosis proteins and nucleic acids and methods for making and using themUNIV CALIFORNIA·Filed 2002·Granted Feb 6, 2007·4 cites·29 claims
- 2481US2025223338A1Non-immunogenic single domain antibodiesINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2579US6228603B1Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activityBURNHAM INST·Filed 1998·Granted May 8, 2001·32 cites·17 claims
- 2676US11976126B2Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cellsINHIBRX INC·Filed 2021·Granted May 7, 2024·0 cites·24 claims
- 2776US11965017B2Serpin fusion polypeptides and methods of use thereofINHIBRX INC·Filed 2020·Granted Apr 23, 2024·0 cites·5 claims
- 2875US2025092137A1Multispecific polypeptide constructs containing a constrained cd3 binding domain and a receptor binding region and methods of using the sameINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2974US11827691B2Serpin fusion polypeptides and methods of use thereofINHIBRX INC·Filed 2020·Granted Nov 28, 2023·0 cites·11 claims
- 3073US7192728B2Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activityBURNHAM INST·Filed 2001·Granted Mar 20, 2007·4 cites·42 claims
- 3173US2024166744A1Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereofINHIBRX INC·Filed 2023·Application pending·0 cites
- 3273US2024101704A1Multispecific polypeptide constructs having constrained cd3 binding and methods of using the sameINHIBRX INC·Filed 2023·Application pending·0 cites
- 3372US12227584B2Multivalent and multispecific OX40-binding fusion proteinsINHIBRX BIOSCIENCES INC·Filed 2021·Granted Feb 18, 2025·0 cites·18 claims
- 3472US8173128B2Methods and compositions for inducing apoptosis in cancer cells with an anti-DR5 antibodyNASOFF MARC·Filed 2006·Granted May 8, 2012·2 cites·17 claims
- 3571US11566078B2PDL1-binding proteinsINHIBRX INC·Filed 2019·Granted Jan 31, 2023·0 cites·22 claims
- 3671US2021317205A1Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereofINHIBRX INC·Filed 2021·Application pending·0 cites
- 3770US11117973B2Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasmsINHIBRX INC·Filed 2019·Granted Sep 14, 2021·0 cites·39 claims
- 3870US2020102371A1Serpin fusion polypeptides and methods of use thereofINHIBRX LP·Filed 2019·Application pending·0 cites
- 3969US2022324944A1Serpin fusion polypeptides and methods of use thereofINHIBRX INC·Filed 2021·Application pending·0 cites
- 4066US2020140525A1Non-Immunogenic Single Domain AntibodiesINHIBRX INC·Filed 2019·Application pending·0 cites
- 4165US10745466B2Type III secretion system targeting moleculesINHIBRX INC·Filed 2019·Granted Aug 18, 2020·0 cites·33 claims
- 4265US7786347B2Inhibitor of apoptosis proteins and nucleic acids and methods for making and using themBURNHAM INST MEDICAL RESEARCH·Filed 2007·Granted Aug 31, 2010·0 cites·22 claims
- 4363US10844129B2Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acidsINHIBRX INC·Filed 2018·Granted Nov 24, 2020·0 cites·34 claims
- 4462US7794961B2Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activitySANFORD BURNHAM MEDICAL RES IN·Filed 2007·Granted Sep 14, 2010·0 cites·27 claims
- 4559US12195533B2Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the sameINHIBRX BIOSCIENCES INC·Filed 2019·Granted Jan 14, 2025·0 cites·27 claims
- 4659US11319377B2Monoclonal antibodies and methods of useELANCO TIERGESUNDHEIT AG·Filed 2017·Granted May 3, 2022·0 cites·15 claims
- 4756US2016251435A1Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereofINHIBRX LLC·Filed 2015·Application pending·0 cites
- 4856US2012094922A1Screening assays for agents that alter inhibitor of apoptosis (iap) protein regulation of caspase activityREED JOHN C·Filed 2011·Application pending·0 cites
- 4955US8071327B2Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activityREED JOHN C·Filed 2010·Granted Dec 6, 2011·0 cites·24 claims
- 5055US2023331846A1Canine PD-1-Binding Polypeptides and Uses ThereofINHIBRX INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Quinn Deveraux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →